依达拉奉对脑缺血再灌注后FADD、caspase-8表达的影响被引量：8

Effect of Edaravone on FADD and caspase-8 Protein Expression Following Focal Cerebral Ischemia/Reperfusion

下载PDF

导出

摘要目的研究大鼠脑缺血再灌注后Fas相关死亡域蛋白(FADD)、caspase-8蛋白的表达及依达拉奉对其的影响。方法用免疫组化法测定缺血2 h后再灌注不同时相缺血半暗带FADD、caspase-8蛋白的表达。结果缺血半暗带皮质内FADD、caspase-8蛋白的表达于缺血再灌注后3 h明显上升,再灌注12 h达高峰(P<0.01),至再灌后24 h明显下降。依达拉奉能显著下调其表达(P<0.01,P<0.05)。结论脑缺血再灌注后缺血半暗带FADD、caspase-8蛋白的表达均明显增加,提示二者可能在脑缺血再灌注损伤中发挥重要作用,依达拉奉可能通过抑制其表达而达到脑保护的作用。 Objective To study the protein expressions of Fas-associated with death domain protein （FADD） and caspase-8, and the effects of edaravone on them. Methods The rats were subjected to the middle cerebral artery occlusion for two hours, then killed at different time points after reperfusion. The protein expressions of FADD and caspase-8 were detected by immunohisto-chemistry. Results The protein expressions of FADD and caspase-8 were markedly increased at 3 h after reperfusion in the penumbra of rat cortex, and peaked at 12 h （P〈0.01）, then declined quickly at 24 h. Edaravone treatment could significantly downregulate the FADD and caspase-8 protein expressions after 3 h of reperfusion （P〈0. 01, P〈0.05）, Conclusions FADD and caspase-8 may play important roles in the cerebral ischemia and reperfusion injury. Edaravone could protect neurons from ischemic damage by decrease the expression levels of FADD and caspase-8.

作者胡跃强肖波毕方方丁玲

机构地区中南大学湘雅医院神经内科

出处《中国神经免疫学和神经病学杂志》 CAS 2007年第1期20-22,I0002,共4页 Chinese Journal of Neuroimmunology and Neurology

基金国家自然科学基金资助项目(30370514)

关键词脑缺血 FADD CASPASE-8 依达拉奉 cerebral isehemia FADD caspase-8 edaravone

分类号 R734.1 [医药卫生—肿瘤]

引文网络
相关文献

参考文献10

1Chinnaiyan AM,O'Rourke K,Tewari M,et al.FADD,a novel death domain-containing protein,interacts with the death domain of Fas and initiates apoptosis[J].Cell,1995,81(19):505-512.
2Longa EZ,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20(1):84-91.
3Hsu H,Shu HB,Pan MG,et al.TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor1 signal transduction pathways[J].Cell,1996,84(2):299-308.
4Chinnaiyan AM,ORourke K,Yu GL,et al.Signal transdution by DR3,a death domain-containing receptor related to TNFR-1 and CD95[J].Science,1996,274:990-992.
5Chaudhary PM,Eby M,Jasmin A,et al.Death receptor 5,a new member of the TNFR family,and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway[J].Immunity,1997,7(6):821-830.
6Juo P,Woo MS,Koo CJ,et al.FADD is required for multiple signaling events downstream of the receptor Fas[J].Cell Growth Difer,1999,10 (12):797-804.
7Zhang J,Cade D,Chen A,et al.Fas-mediated apoptosis and acivation induced T-cell proliferation are defective in mice lacking FADD/Mort[J].Nature,1998,392(19):296-303.
8Jin Kl,Graham SH,Mao XO,et al.Fas (CD95) may mediate delayed cell death in Hippocampal CA1 sector after global cerebral ischemia[J].Cereb Blood Flow Metab,2001,21(12):1411-1421.
9Rajesh KG,Sasaguri S,Suzuki R,et al.Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression[J].Am J Physiol Heart Circ Physiol,2003,5:2171-2178.
10Zhang N,Komine-Kobayashi M,Tanaka R,et al.Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain[J].Stroke,2005,36(10):2220-2225.